Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Ethereum was built with Turing-complete smart contracts, unlike Bitcoin. This explanation covers the architectural reasons and practical impact.
28,405 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Public tours of Jim Henson's Creature Shop in Queens reveal the hidden craft behind Kermit and friends. The 80-minute...
An overlooked cleantech fund just delivered a powerful start to 2026, posting double-digit gains year-to-date and ecl...
Clive Davis, the legendary talent scout who built Arista and launched icons like Whitney Houston, has died at age 94,...
Medicare’s 2027 Part B premium is projected to rise from current levels, potentially crossing the $210 mark and appro...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
A $300,000 retirement stash can fund about $12,000 per year at a 4% withdrawal pace, but longevity risk and medical c...
A Reagan Institute survey shows two-thirds of voters are upbeat on American-led innovation, spanning parties and gene...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
Memory-chip stocks tumbled after a Korean market crash rippled into U.S. markets, led by SanDisk and Micron as risk-o...
A fabless-focused ETF has surged roughly 58% this year as AI-driven design gains power, all while avoiding the world'...
A 68-year-old retiree faced a surprise tax bill after selling $30,000 of stock. The move pushed provisional income ov...